Showing the single result

  • Hertraz 440 mg Trastuzumab Infusion Vial

    Hertraz 440 MG (Trastuzumab)

    0 out of 5
    Price range: $1,555 through $4,355

    Hertraz 440 mg (Trastuzumab Intravenous Infusion) is a monoclonal antibody that targets the HER2 receptor, used in the treatment of HER2-positive breast and gastric cancers. Administered by IV infusion under medical supervision, Hertraz helps inhibit tumor growth and may reduce recurrence when combined with chemotherapy. Trusted in oncology for its targeted action and proven efficacy.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page

End of content

End of content